Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Misoprostol 400 vs 800 mcg for Missed Miscarriage
NCT05103098Unknown
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in missed abortion (2 arms). Primary endpoint: Completeness of abortion at 7 days. Status: unknown.
02
Drugs
misoprostol
03
Conditions
missed abortion
Beyond the preview
Go deeper on NCT05103098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103098.